These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32215224)

  • 41. Early Antibody Response Contributes to the Virus Eradication and Clinical Recovery of H7N9 Influenza Infection.
    Liu X; Yang Z; Yuan J; Liao J; Duan L; Wang W; Zhang F; Chen X; Zhou B
    Ann Clin Lab Sci; 2017 Sep; 47(5):592-599. PubMed ID: 29066487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of H7N9 avian influenza viruses isolated from duck meat products.
    Wu L; Mitake H; Kiso M; Ito M; Iwatsuki-Hirimoto K; Yamayoshi S; Lopes TJS; Feng H; Sumiyoshi R; Shibata A; Osaka H; Imai M; Watanabe T; Kawaoka Y
    Transbound Emerg Dis; 2020 Mar; 67(2):792-798. PubMed ID: 31650680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
    Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
    J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Behavioral and ecological infectious diseases: from SARS to H7N9 avian influenza outbreak in China].
    Xu JG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):417-8. PubMed ID: 24016425
    [No Abstract]   [Full Text] [Related]  

  • 46. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
    Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
    J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating the Distribution of the Incubation Periods of Human Avian Influenza A(H7N9) Virus Infections.
    Virlogeux V; Li M; Tsang TK; Feng L; Fang VJ; Jiang H; Wu P; Zheng J; Lau EH; Cao Y; Qin Y; Liao Q; Yu H; Cowling BJ
    Am J Epidemiol; 2015 Oct; 182(8):723-9. PubMed ID: 26409239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [An analysis on HA, NA gene/protein evolution and the variability of antigenicity sites of influenza A (H7N9) virus].
    Li H; Hu P
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(30):2381-4. PubMed ID: 24300207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
    Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
    J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 'Outbreak Gold Standard' selection to provide optimized threshold for infectious diseases early-alert based on China Infectious Disease Automated-alert and Response System.
    Wang RP; Jiang YG; Zhao GM; Guo XQ; Michael E
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):833-841. PubMed ID: 29270740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China.
    Su S; Gu M; Liu D; Cui J; Gao GF; Zhou J; Liu X
    Trends Microbiol; 2017 Sep; 25(9):713-728. PubMed ID: 28734617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inference and forecast of H7N9 influenza in China, 2013 to 2015.
    Li R; Bai Y; Heaney A; Kandula S; Cai J; Zhao X; Xu B; Shaman J
    Euro Surveill; 2017 Feb; 22(7):. PubMed ID: 28230525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical severity of human infections with avian influenza A(H7N9) virus, China, 2013/14.
    Feng L; Wu JT; Liu X; Yang P; Tsang TK; Jiang H; Wu P; Yang J; Fang VJ; Qin Y; Lau EH; Li M; Zheng J; Peng Z; Xie Y; Wang Q; Li Z; Leung GM; Gao GF; Yu H; Cowling BJ
    Euro Surveill; 2014 Dec; 19(49):. PubMed ID: 25523971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Li L; DeLiberto TJ; Killian ML; Torchetti MK; Wan XF
    Virology; 2018 Dec; 525():32-39. PubMed ID: 30236990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses.
    Chen WA; Zhang J; Hall KM; Martin CB; Kisselev S; Dasen EJ; Vahanian NN; Link CJ; Martin BK
    PLoS One; 2017; 12(8):e0182683. PubMed ID: 28787006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The first confirmed pediatric case with H7N9 avian influenza virus infection in China].
    Zeng M; Zhu YF; Ge YL; Xia AM; Pu DB; Yu H; Wang XH; Zhu QR
    Zhonghua Er Ke Za Zhi; 2013 Sep; 51(9):665-9. PubMed ID: 24330985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of human avian influenza A(H7N9) virus infections in Wenshan City in Southwest China, 2017.
    Jiang L; Zhao X; Xu W; Zhou X; Luo C; Zhou J; Fu X; Chen Y; Li D
    BMC Infect Dis; 2020 Feb; 20(1):154. PubMed ID: 32075579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid genome sequencing and characterization of novel avian-origin influenza A H7N9 virus directly from clinical sample by semiconductor sequencing.
    Hu Y; Ren X; Li L; Xiao Y; Dong J; Sun L; Zhu Y; Yang F; Zhang X; Jin Q
    J Clin Virol; 2015 Dec; 73():84-88. PubMed ID: 26580409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    Liu L; Nachbagauer R; Zhu L; Huang Y; Xie X; Jin S; Zhang A; Wan Y; Hirsh A; Tian D; Shi X; Dong Z; Yuan S; Hu Y; Krammer F; Zhang X; Xu J
    J Infect Dis; 2017 Feb; 215(4):518-528. PubMed ID: 28380622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.